WHO finds uneven respiratory virus activity in week 44 surveillance update
Global influenza test positivity was below 10% in the week ending 1 November. Sample rates are not population infection rates.
Event / data period:
Published: · Updated:

A World Health Organization weekly surveillance update published on 11 November found that influenza positivity remained below 10 percent globally in week 44, which ended on 1 November. The headline conceals sharply different patterns between broad regions. Positivity continued to rise in northern temperate and subtropical areas, remained below 5 percent in southern temperate and subtropical areas, and was above 10 percent in tropical areas.
These figures describe the share of tested specimens that were positive within surveillance systems. They are not estimates of the share of people infected, nor a count of all infections in the population. WHO says the report combines sentinel surveillance with other systematic virologic monitoring, and that countries use different methods and testing practices. The denominator is therefore the specimens reported for testing, not the total population.
Influenza detections remained low in WHO's global summary, with influenza A predominant. Yet the map of elevated positivity was mixed. In the northern hemisphere, some countries in Central America and the Caribbean, Northern Europe, and Southern and Eastern Asia exceeded 10 percent positivity. WHO reported rates above 30 percent in some countries in Central America and the Caribbean and parts of Western, Southern and South Eastern Asia, as well as individual countries in Western and Eastern Africa.
The southern hemisphere also contained local increases despite its lower broad regional summary. Positivity was above 10 percent in some countries in Tropical South America and Oceania, and in individual countries in Temperate South America and Eastern Africa. One country in South Eastern Asia exceeded 30 percent. WHO reported increasing activity in one country in Tropical South America. A broad hemispheric average can therefore move in a different direction from a local national signal.
The circulating influenza types also varied by transmission zone. In zones with elevated positivity, A(H1N1)pdm09 was predominant in Northern Europe, Eastern Africa, Western and South Eastern Asia, and Oceania. In Eastern Asia, A(H1N1)pdm09 and A(H3N2) were co-dominant. Influenza A and B were co-dominant in Central America and the Caribbean, Temperate South America, and Southern Asia. Influenza B was predominant in Tropical South America, Western Africa, and Middle Africa.
The update described SARS-CoV-2 positivity as stable and low across most reporting countries, while recording pockets above 10 percent in parts of South Western Europe and single countries in Central America and the Caribbean, Northern Europe, and Western Asia. One country in Northern Africa was above 30 percent. WHO also noted small increases in several named areas. These are surveillance signals for the reporting week, not evidence that every country or community followed the same trend.
RSV positivity remained low globally in the report, but local readings exceeded 10 percent in a few countries in Central America and the Caribbean and in single countries in Tropical South America, Southern Asia, and Eastern Asia. Rates over 30 percent were reported in individual countries in Temperate South America and Southern Asia. Some areas reported elevated influenza and RSV at the same time, while the source cautions that different viruses may be sampled from different surveillance sources.
WHO's severity section is a separate kind of national report. In northern temperate and subtropical areas, influenza-specific transmissibility was below the local seasonal threshold in 10 countries and classified as low in six; assessments based on syndromic data were below threshold in seven and low in one. The report says these assessments use each country's historical context and methods. They should not be ranked as though one country used an identical scale to another.
The report's methods explain why the maps smooth short-term movements. For influenza and SARS-CoV-2 trend analysis, WHO averaged positivity over three weeks and included countries that tested at least 10 specimens in at least two of those three weeks. Influenza subtype maps aggregate three weeks backward until a transmission zone reaches at least 100 tested samples. Those thresholds apply to specified analytical products, not to all figures in the bulletin.
WHO says reporting completeness can change, countries can revise prior data, and grouped regions do not imply uniform transmission inside them. The summary was based on RespiMart data last updated on 9 November at 00:30 UTC, two days before publication. Newsverum reviewed the bulletin and its methods. The update supports a picture of uneven activity and changing test positivity, not a diagnosis, a forecast, or a direct comparison of infection risk between populations.
Data
WHO weekly surveillance period
Week 44 ended on 1 November 2026; the bulletin was published on 11 November.
- · Occurred
End of the week covered by the WHO surveillance update
Week 44 ended on 1 November 2026; the bulletin was published on 11 November.
Methodology
The source distinguishes the week end from report publication date.
Updated:
Global influenza test positivity
WHO reported global influenza positivity below 10% for week 44. The measure is a share of tested specimens.
- Upper bound of influenza specimen positivity globally
- ≤10 percent
- 2026-10-26 - 2026-11-01 · Observed
Methodology
Virologic specimens reported by countries contributing to WHO FluNet and GISRS. The 10% upper bound represents WHO’s finding of below 10%. The denominator is tested specimens, not people.
Updated:
Subjects and places
Subject proposals
- Communicable diseaseSuggested
- Subject suggested from the title or summary: influenzawww.who.int ↗cdn.who.int ↗